CN111850053A - 使用合成气的多级合成方法 - Google Patents
使用合成气的多级合成方法 Download PDFInfo
- Publication number
- CN111850053A CN111850053A CN202010735971.6A CN202010735971A CN111850053A CN 111850053 A CN111850053 A CN 111850053A CN 202010735971 A CN202010735971 A CN 202010735971A CN 111850053 A CN111850053 A CN 111850053A
- Authority
- CN
- China
- Prior art keywords
- clostridium
- acetate
- microorganism
- ethanol
- moorella
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 99
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 25
- 238000003786 synthesis reaction Methods 0.000 title claims abstract description 21
- 244000005700 microbiome Species 0.000 claims abstract description 46
- 239000007789 gas Substances 0.000 claims abstract description 26
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 22
- 239000004215 Carbon black (E152) Substances 0.000 claims abstract description 20
- 125000004430 oxygen atom Chemical group O* 0.000 claims abstract description 18
- 229910002091 carbon monoxide Inorganic materials 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 119
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 66
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 54
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 31
- 229910052799 carbon Inorganic materials 0.000 claims description 31
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 25
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 22
- 150000002430 hydrocarbons Chemical group 0.000 claims description 19
- 241000894006 Bacteria Species 0.000 claims description 18
- 241000193403 Clostridium Species 0.000 claims description 18
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 15
- 229930195729 fatty acid Natural products 0.000 claims description 15
- 239000000194 fatty acid Substances 0.000 claims description 15
- 241000186566 Clostridium ljungdahlii Species 0.000 claims description 12
- 239000001569 carbon dioxide Substances 0.000 claims description 11
- 230000000789 acetogenic effect Effects 0.000 claims description 10
- 230000000694 effects Effects 0.000 claims description 10
- 150000004665 fatty acids Chemical class 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 9
- 241000178985 Moorella Species 0.000 claims description 7
- 102000005488 Thioesterase Human genes 0.000 claims description 7
- XTAZYLNFDRKIHJ-UHFFFAOYSA-N n,n-dioctyloctan-1-amine Chemical compound CCCCCCCCN(CCCCCCCC)CCCCCCCC XTAZYLNFDRKIHJ-UHFFFAOYSA-N 0.000 claims description 7
- 108020002982 thioesterase Proteins 0.000 claims description 7
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims description 6
- 241000193459 Moorella thermoacetica Species 0.000 claims description 5
- 241000563903 Bacillus velezensis Species 0.000 claims description 4
- 241000620141 Carboxydothermus Species 0.000 claims description 4
- 241000193171 Clostridium butyricum Species 0.000 claims description 4
- 241000205276 Methanosarcina Species 0.000 claims description 4
- 241000194017 Streptococcus Species 0.000 claims description 4
- 150000001298 alcohols Chemical class 0.000 claims description 4
- 150000001735 carboxylic acids Chemical class 0.000 claims description 4
- 230000029087 digestion Effects 0.000 claims description 4
- ABVVEAHYODGCLZ-UHFFFAOYSA-N tridecan-1-amine Chemical compound CCCCCCCCCCCCCN ABVVEAHYODGCLZ-UHFFFAOYSA-N 0.000 claims description 4
- BWLBGMIXKSTLSX-UHFFFAOYSA-N 2-hydroxyisobutyric acid Chemical class CC(C)(O)C(O)=O BWLBGMIXKSTLSX-UHFFFAOYSA-N 0.000 claims description 3
- 241001468163 Acetobacterium woodii Species 0.000 claims description 3
- 241001656810 Clostridium aceticum Species 0.000 claims description 3
- 241001656809 Clostridium autoethanogenum Species 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 150000001299 aldehydes Chemical class 0.000 claims description 3
- 150000003973 alkyl amines Chemical class 0.000 claims description 3
- 150000001733 carboxylic acid esters Chemical class 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 150000001991 dicarboxylic acids Chemical class 0.000 claims description 3
- 238000011065 in-situ storage Methods 0.000 claims description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 3
- 241001112780 Acetoanaerobium Species 0.000 claims description 2
- 241000589220 Acetobacter Species 0.000 claims description 2
- 241001464894 Blautia producta Species 0.000 claims description 2
- 241001611022 Clostridium carboxidivorans Species 0.000 claims description 2
- 241000193161 Clostridium formicaceticum Species 0.000 claims description 2
- 241000186398 Eubacterium limosum Species 0.000 claims description 2
- 241000205284 Methanosarcina acetivorans Species 0.000 claims description 2
- 241000205275 Methanosarcina barkeri Species 0.000 claims description 2
- 241000186544 Moorella thermoautotrophica Species 0.000 claims description 2
- 241001509483 Oxobacter pfennigii Species 0.000 claims description 2
- 241000191992 Peptostreptococcus Species 0.000 claims description 2
- 241000186429 Propionibacterium Species 0.000 claims description 2
- 241000205160 Pyrococcus Species 0.000 claims description 2
- 241000204649 Thermoanaerobacter kivui Species 0.000 claims description 2
- 150000007513 acids Chemical class 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 150000002576 ketones Chemical class 0.000 claims description 2
- DIAIBWNEUYXDNL-UHFFFAOYSA-N n,n-dihexylhexan-1-amine Chemical group CCCCCCN(CCCCCC)CCCCCC DIAIBWNEUYXDNL-UHFFFAOYSA-N 0.000 claims description 2
- 238000004062 sedimentation Methods 0.000 claims description 2
- 244000037614 Trachycarpus fortunei Species 0.000 claims 1
- 159000000021 acetate salts Chemical class 0.000 abstract description 3
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 3
- 235000019441 ethanol Nutrition 0.000 description 38
- 239000000243 solution Substances 0.000 description 22
- 238000000855 fermentation Methods 0.000 description 20
- 230000004151 fermentation Effects 0.000 description 20
- 239000002609 medium Substances 0.000 description 19
- 238000004519 manufacturing process Methods 0.000 description 18
- 241000588724 Escherichia coli Species 0.000 description 11
- 241000235015 Yarrowia lipolytica Species 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- 235000013619 trace mineral Nutrition 0.000 description 9
- 239000011573 trace mineral Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 7
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 229940088594 vitamin Drugs 0.000 description 7
- 229930003231 vitamin Natural products 0.000 description 7
- 235000013343 vitamin Nutrition 0.000 description 7
- 239000011782 vitamin Substances 0.000 description 7
- DBXBTMSZEOQQDU-UHFFFAOYSA-N 3-hydroxyisobutyric acid Chemical compound OCC(C)C(O)=O DBXBTMSZEOQQDU-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 150000003722 vitamin derivatives Chemical class 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 238000002309 gasification Methods 0.000 description 4
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000002054 inoculum Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 4
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 239000002028 Biomass Substances 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241001379910 Ephemera danica Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 239000012154 double-distilled water Substances 0.000 description 3
- -1 fatty acid esters Chemical class 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 125000005270 trialkylamine group Chemical group 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- 102100020959 Alpha/beta hydrolase domain-containing protein 17C Human genes 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241000186570 Clostridium kluyveri Species 0.000 description 2
- 241001611023 Clostridium ragsdalei Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- 241000235649 Kluyveromyces Species 0.000 description 2
- XOGTZOOQQBDUSI-UHFFFAOYSA-M Mesna Chemical compound [Na+].[O-]S(=O)(=O)CCS XOGTZOOQQBDUSI-UHFFFAOYSA-M 0.000 description 2
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 description 2
- HPEUJPJOZXNMSJ-UHFFFAOYSA-N Methyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC HPEUJPJOZXNMSJ-UHFFFAOYSA-N 0.000 description 2
- 235000014676 Phragmites communis Nutrition 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000007640 basal medium Substances 0.000 description 2
- GONOPSZTUGRENK-UHFFFAOYSA-N benzyl(trichloro)silane Chemical compound Cl[Si](Cl)(Cl)CC1=CC=CC=C1 GONOPSZTUGRENK-UHFFFAOYSA-N 0.000 description 2
- 238000010364 biochemical engineering Methods 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- 239000012159 carrier gas Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- 239000006184 cosolvent Substances 0.000 description 2
- 229960001305 cysteine hydrochloride Drugs 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 229960004635 mesna Drugs 0.000 description 2
- 230000037353 metabolic pathway Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- YRHYCMZPEVDGFQ-UHFFFAOYSA-N methyl decanoate Chemical compound CCCCCCCCCC(=O)OC YRHYCMZPEVDGFQ-UHFFFAOYSA-N 0.000 description 2
- UQDUPQYQJKYHQI-UHFFFAOYSA-N methyl laurate Chemical compound CCCCCCCCCCCC(=O)OC UQDUPQYQJKYHQI-UHFFFAOYSA-N 0.000 description 2
- JGHZJRVDZXSNKQ-UHFFFAOYSA-N methyl octanoate Chemical compound CCCCCCCC(=O)OC JGHZJRVDZXSNKQ-UHFFFAOYSA-N 0.000 description 2
- ZAZKJZBWRNNLDS-UHFFFAOYSA-N methyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC ZAZKJZBWRNNLDS-UHFFFAOYSA-N 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000010265 sodium sulphite Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- NMRPBPVERJPACX-UHFFFAOYSA-N (3S)-octan-3-ol Natural products CCCCCC(O)CC NMRPBPVERJPACX-UHFFFAOYSA-N 0.000 description 1
- WOFPPJOZXUTRAU-UHFFFAOYSA-N 2-Ethyl-1-hexanol Natural products CCCCC(O)CCC WOFPPJOZXUTRAU-UHFFFAOYSA-N 0.000 description 1
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 1
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- 101710120269 Acyl-CoA thioester hydrolase YbgC Proteins 0.000 description 1
- 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 description 1
- 102100025848 Acyl-coenzyme A thioesterase 8 Human genes 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000228439 Bipolaris zeicola Species 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 244000060020 Chamaerops excelsa Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 241001112695 Clostridiales Species 0.000 description 1
- 241001256038 Clostridium ljungdahlii DSM 13528 Species 0.000 description 1
- 229910021592 Copper(II) chloride Inorganic materials 0.000 description 1
- 241000219992 Cuphea Species 0.000 description 1
- 240000006262 Cuphea hookeriana Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 108010005054 Deoxyribonuclease BamHI Proteins 0.000 description 1
- 102100030787 ERI1 exoribonuclease 2 Human genes 0.000 description 1
- 241000380130 Ehrharta erecta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 101000938751 Homo sapiens ERI1 exoribonuclease 2 Proteins 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 239000005640 Methyl decanoate Substances 0.000 description 1
- 239000005641 Methyl octanoate Substances 0.000 description 1
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 229910018890 NaMoO4 Inorganic materials 0.000 description 1
- 229910021586 Nickel(II) chloride Inorganic materials 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 241000029538 [Mannheimia] succiniciproducens Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 108700021044 acyl-ACP thioesterase Proteins 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- XGGLLRJQCZROSE-UHFFFAOYSA-K ammonium iron(iii) sulfate Chemical compound [NH4+].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O XGGLLRJQCZROSE-UHFFFAOYSA-K 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- HJMZMZRCABDKKV-UHFFFAOYSA-N carbonocyanidic acid Chemical compound OC(=O)C#N HJMZMZRCABDKKV-UHFFFAOYSA-N 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 229940060799 clarus Drugs 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- GVPFVAHMJGGAJG-UHFFFAOYSA-L cobalt dichloride Chemical compound [Cl-].[Cl-].[Co+2] GVPFVAHMJGGAJG-UHFFFAOYSA-L 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- PYRZPBDTPRQYKG-UHFFFAOYSA-N cyclopentene-1-carboxylic acid Chemical compound OC(=O)C1=CCCC1 PYRZPBDTPRQYKG-UHFFFAOYSA-N 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000010459 dolomite Substances 0.000 description 1
- 229910000514 dolomite Inorganic materials 0.000 description 1
- QYDYPVFESGNLHU-UHFFFAOYSA-N elaidic acid methyl ester Natural products CCCCCCCCC=CCCCCCCCC(=O)OC QYDYPVFESGNLHU-UHFFFAOYSA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- CAMHHLOGFDZBBG-UHFFFAOYSA-N epoxidized methyl oleate Natural products CCCCCCCCC1OC1CCCCCCCC(=O)OC CAMHHLOGFDZBBG-UHFFFAOYSA-N 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000003546 flue gas Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- QYDYPVFESGNLHU-KHPPLWFESA-N methyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC QYDYPVFESGNLHU-KHPPLWFESA-N 0.000 description 1
- 229940073769 methyl oleate Drugs 0.000 description 1
- IZFGRAGOVZCUFB-HJWRWDBZSA-N methyl palmitoleate Chemical compound CCCCCC\C=C/CCCCCCCC(=O)OC IZFGRAGOVZCUFB-HJWRWDBZSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 239000003345 natural gas Substances 0.000 description 1
- QMMRZOWCJAIUJA-UHFFFAOYSA-L nickel dichloride Chemical compound Cl[Ni]Cl QMMRZOWCJAIUJA-UHFFFAOYSA-L 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 238000012809 post-inoculation Methods 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011684 sodium molybdate Substances 0.000 description 1
- 235000015393 sodium molybdate Nutrition 0.000 description 1
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 1
- 239000011655 sodium selenate Substances 0.000 description 1
- 235000018716 sodium selenate Nutrition 0.000 description 1
- 229960001881 sodium selenate Drugs 0.000 description 1
- XMVONEAAOPAGAO-UHFFFAOYSA-N sodium tungstate Chemical compound [Na+].[Na+].[O-][W]([O-])(=O)=O XMVONEAAOPAGAO-UHFFFAOYSA-N 0.000 description 1
- RBJZIQZDAZLXEK-UHFFFAOYSA-M sodium;3-hydroxy-2-methylpropanoate Chemical compound [Na+].OCC(C)C([O-])=O RBJZIQZDAZLXEK-UHFFFAOYSA-M 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000000629 steam reforming Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 125000005472 straight-chain saturated fatty acid group Chemical group 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/06—Ethanol, i.e. non-beverage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/06—Ethanol, i.e. non-beverage
- C12P7/065—Ethanol, i.e. non-beverage with microorganisms other than yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/42—Hydroxy-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/44—Polycarboxylic acids
- C12P7/46—Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/54—Acetic acid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明涉及使用合成气的多级合成方法。具体地,本发明提供了一种制备烃的方法,所述烃被至少一个含有至少一个氧原子的基团取代,所述方法包括以下方法步骤:A)使包含至少一种选自CO2和CO的物质的碳源与第一种微生物反应,以产生乙酸盐和/或乙醇,B)从所述第一种微生物分离出所述乙酸盐,C)使所述乙酸盐与第二种微生物反应,以产生被至少一个含有至少一个氧原子的基团取代的烃,和任选地D)纯化所述被至少一个含有至少一个氧原子的基团取代的烃。
Description
本专利申请是申请号为201380024696.5,申请日为2013年5月8日,同题的母案专利申请的分案申请。
技术领域
本发明的主题是制备烃的方法,所述烃被至少一个含有至少一个氧原子的基团取代,所述方法包括以下方法步骤:
A) 用第一种微生物将碳源转化成乙酸盐和/或乙醇,所述碳源包含选自CO2和CO的至少一种,
B) 将所述第一种微生物与所述乙酸盐和/或乙醇分离,
C) 用第二种微生物将所述乙酸盐和/或乙醇转化成烃,所述烃被至少一个含有至少一个氧原子的基团取代,和任选地
D) 纯化所述被至少一个含有至少一个氧原子的基团取代的烃。
背景技术
在文献中经常描述CO2作为碳源在以微生物方法合成有机化合物中的用途。
通常,在现有技术中尝试在重组细胞中构建得自不同生物体的2个互补代谢途径,然后可以在其帮助下合成有机物质。
在这里产生的问题是,意在将其性能组合在一起的不同生物体是生态位中非常高特异性化的生物,且因此难以将与其有关的所有优点的总和合并在一个细胞中。另外,这些生物体的遗传可达性的缺乏会给所希望的操作造成困难。
使用CO2作为碳源的替代方法通过发酵参数的某种选择影响已知能够固定CO2的微生物,使得所述微生物增加合成所希望的、简单的有机物质,例如,乙醇、正丁醇或2,3-丁二醇。
WO200068407描述了产乙酸细菌在乙醇制备中的用途,WO2012024522描述了产乙酸细菌在丁二醇制备中的用途。
所有描述的方法具有以下缺点:收率低,并且单一细胞类型的使用不能实现发酵条件下的灵活性。
本发明的目的是,提供能够克服现有技术的至少一种缺点的方法。
发明内容
已经令人惊奇地发现,下面描述的具有将乙酸盐-继续加工的乙酸盐-产物与CO2和/或CO分离的多级方法能够以最简单的方式克服现有技术的缺点。
因此,本发明提供了如权利要求1和其它独立权利要求中描述的方法。
本发明的一个优点是,CO2/CO混合物是基本上更有利的原料,其此外可以由多种来源,诸如天然气和生物气、煤、油、以及植物残余物制备。
本发明的方法的另一个优点是高碳收率。这可通过返回所形成的CO2实现。因为,CO2可以在第一级中再次转化成乙酸。
另一个优点在于,在使用的发酵条件方面的更大的灵活性,因为对于根据本发明的方法步骤C)中的实际生产而言,在乙酸盐加工中使用的生物不同于用于碳固定的生物。
本发明的再一个优点是,与在方法步骤C)中使用糖相比,通过在方法步骤C)中使用乙酸盐和/或乙醇、特别是乙酸盐作为碳源,可以产生不同的产物组合物。
本发明提供了一种制备烃的方法,所述烃被至少一个含有至少一个氧原子的基团取代,所述方法包括以下方法步骤:
A) 用第一种微生物将碳源转化成乙酸盐和/或乙醇,尤其是乙酸盐,所述碳源包含选自CO2和CO的至少一种,
B) 将所述第一种微生物与所述乙酸盐和/或乙醇分离,尤其是乙酸盐,
C) 用第二种微生物将所述乙酸盐和/或乙醇,尤其是乙酸盐,转化成烃,所述烃被至少一个含有至少一个氧原子的基团取代,和任选地
D) 纯化所述烃,其被至少一个含有至少一个氧原子的基团取代,优选具有至少3个、尤其是至少4个碳原子。
在本发明的上下文中,术语“乙酸盐”应当理解为是指乙酸以及它的盐;这是必然得出的,因为微生物在水性介质中工作,并因此总是存在盐和酸之间的平衡。
在本发明的上下文中,术语“第二种微生物”应当理解为是指与得自方法步骤A)的“第一种微生物”不同的微生物。
除非另外说明,所有给出的百分比(%)都是质量百分比。
在根据本发明的方法中,在方法步骤A)中,第一种微生物由包含二氧化碳和/或一氧化碳的碳源形成乙酸盐和/或乙醇;该表述包含乙酸盐和/或乙醇至少部分地由二氧化碳和/或一氧化碳形成。
关于底物二氧化碳和/或一氧化碳的来源,显而易见,存在许多可能的来源用于提供CO和/或CO2作为碳源。显然,在实践中,可以使用能够给微生物供应足量的碳以使它们能形成乙酸盐和/或乙醇的任何气体或任何气体混合物均可用作本发明的碳源。
在根据本发明的方法中,优选的是,通过废气例如合成气、烟道气、炼油厂废气,通过酵母发酵或梭菌发酵形成的气体,由含纤维素的材料的气化或碳气化产生的废气提供所述碳源。
在这方面,特别优选的是,至少部分二氧化碳和/或一氧化碳是根据本发明的方法的方法步骤C)的副产物。这具有以下技术效果:整个方法的碳收率是100%。
这些废气不必必然作为其他工艺的副产物(Nebenerscheinung)而产生,而是可以用在根据本发明的方法中而专门生产。
在根据本发明的方法的一个优选的实施方案中,所述碳源是合成气。
合成气可以例如由碳气化的副产物提供。因此,该微生物将作为废物产物的物质转化成有价值的原料。
可替换地,合成气可以通过气化广泛可提供的、价格便宜的农业原料提供给根据本发明的方法。
可以被转化成合成气的原料存在众多例子,因为几乎所有形式的植物都可以用于该目的。优选的原料选自多年生的草诸如中国芦苇(Chinaschilf),谷类残余物,加工废物诸如锯屑。
一般而言,合成气在气化设备中由干燥的生物质制得,主要通过热解、部分氧化和蒸汽重整,由此主要产物是CO、H2和CO2。
通常,预加工部分产物气体,以优化产物收率和避免焦油形成。可使用石灰和/或白云石将不希望的焦油裂化成合成气和CO。这些方法详细地描述在例如Reed, 1981(Reed, T.B., 1981, Biomass gasification: principles and technology, NovesData Corporation, Park Ridge, NJ.)中。
也可能使用不同来源的混合物作为碳源。
一般而言,在根据本发明的方法中优选的是,在方法步骤A)中的碳源包含至少50重量%、优选地至少70重量%、特别优选地至少90重量%的CO2和/或CO,其中重量%基于在方法步骤A)中微生物可利用的所有碳源计。
在方法步骤A)中,优选地与二氧化碳和/或一氧化碳一起向反应输送还原剂,优选氢。
因此,根据本发明优选的方法的特征在于,在方法步骤A)中的碳源包含合成气,尤其是由合成气组成。
长久以来已知将CO2和/或CO转化成乙酸盐和/或乙醇、尤其是乙酸盐的微生物,以及在方法步骤A)中可以使用的合适方法和工艺条件。这样的方法描述在例如以下文献中:
WO9800558,WO2000014052,WO2010115054
Demler等人. Reaction engineering analysis of hydrogenotrophic production of acetic acid by Acetobacterium woodii. Biotechnol Bioeng. 2011年2月; 108(2): 470-4,
Younesia等人. Ethanol and acetate production from synthesis gas via fermentation processes using anaerobic bacterium, Clostridium ljungdahlii. Biochemical Engineering Journal, 第27卷, 第2期, 第110-119页,
Morinaga等人. The production of acetic acid from carbon dioxide and hydrogen by an anaerobic bacterium.Journal of Biotechnology, 第14卷, 第2期,第187-194页,
Li Production of acetic acid from synthesis gas with mixed acetogenic microorganisms, ISSN 0493644938,
Schmidt等人. Production of acetic acid from hydrogen and carbon dioxide by clostridium species ATCC 2979. Chemical Engineering Communications, 45:1-6, 61-73,
Sim等人. Optimization of acetic acid production from synthesis gas by chemolithotrophic bacterium - Clostridium aceticum using a statistical approach. Bioresour Technol. 2008 May; 99(8):2724-35,
Vega等人. Study of gaseous substrate fermentations CO conversion to acetate 1 Batch culture and 2 continuous culture. Biotechnology andBioengineering 第34卷, 第6期, 第774和785页, 1989年9月,
Cotter等人. Ethanol and acetate production by Clostridium ljungdahlii andClostridium autoethanogenumusing resting cells. Bioprocess and BiosystemsEngineering (2009), 32(3), 369-380,和
Andreesen等人. Fermentation of glucose, fructose, and xylose by Clostridium thermoaceticum. Effect of metals on growth yield, enzymes, and the synthesis of acetate from carbon dioxide. Journal of Bacteriology (1973),114(2), 743-51。
由此给本领域技术人员提供了大量用于设计方法步骤A)的可行的可能性,它们都良好地起作用。
在这方面,特别适合的是产乙酸细菌。产乙酸细菌群体属于厌氧性的原核生物,其可以利用CO2作为末端电子受体,并在该过程中形成乙酸盐和/或乙醇。目前,在产乙酸菌中包括21个不同属(Drake等人, 2006),其中一些也是梭状芽胞杆菌(Drake和Küsel, 2005)。它们能够利用二氧化碳或者一氧化碳作为碳源,并利用氢作为能源(Wood, 1991)。另外,醇、醛、羧酸和众多己糖也可以用作碳源(Drake等人, 2004)。导致乙酸盐形成的还原代谢途径被称作乙酰辅酶A途径或Wood-Ljungdahl途径。
因此,优选的是,在根据本发明的方法的方法步骤A)中,使用产乙酸细菌作为第一种微生物。特别优选的是,使用选自以下的产乙酸细菌:Clostridium autothenogenum DSMZ 19630、拉氏梭菌(Clostridium ragsdahlei)ATCC no. BAA-622、产乙醇梭菌(Clostridium autoethanogenum)、穆尔氏菌属(Moorella sp)HUC22-1、热醋穆尔氏菌(Moorella thermoaceticum)、热自养穆尔氏菌(Moorella thermoautotrophica)、Rumicoccus productus、Acetoanaerobum、普氏产醋杆菌(Oxobacter pfennigii)、巴氏甲烷八叠球菌(Methanosarcina barkeri)、噬乙酸甲烷八叠球菌(Methanosarcina acetivorans)、氧化碳嗜热菌属(Carboxydothermus)、Desulphotomaculum kutznetsovii、热球菌属(Pyrococcus)、消化链球菌属(Peptostreptococcus)、食甲基丁酸杆菌(Butyribacterium methylotrophicum)ATCC 33266、蚁酸醋酸梭菌(Clostridium formicoaceticum)、酪酸梭菌(Clostridium butyricum)、Laktobacillus delbrukii、Propionibacterium acidoprprionici、Proprionispera arboris、Anaerobierspirillum succiniproducens、Bacterioides amylophilus、Becterioides ruminicola、凯伍热厌氧杆菌(Thermoanaerobacter kivui)、伍氏醋酸杆菌(Acetobacterium woodii)、潮湿厌氧醋酸菌(Acetoanaerobium notera)、醋酸梭菌(Clostridium aceticum)、食甲基丁酸杆菌(Butyribacterium methylotrophicum)、热醋穆尔氏菌(Moorella thermoacetica)、产粘真杆菌(Eubacterium limosum)、产生消化链球菌(Peptostreptococcus productus)、扬氏梭菌(Clostridium ljungdahlii)、梭菌属(Clostridium)ATCC 29797和食一氧化碳梭菌(Clostridium carboxidivorans),尤其是ATCC BAA-624。一种特别合适的细菌是食一氧化碳梭菌,尤其是诸如“P7”和“P11”等菌株。这样的细胞描述在例如US 2007/0275447和US2008/0057554中。
另外的特别合适的细菌是扬氏梭菌(Clostridium ljungdahlii),尤其是选自扬氏梭菌PETC、扬氏梭菌ERI2、扬氏梭菌C0l和扬氏梭菌O-52的菌株,这些描述在WO 98/00558和WO 00/68407中,以及ATCC 49587、ATCC 55988和ATCC 55989。
在根据本发明的方法的一个特别优选的实施方案中,在方法步骤A)中,形成乙醇,且使用的微生物是Alkalibaculum bacchi ATCC BAA-1772、穆尔氏菌属HUC22-1、扬氏梭菌、拉氏梭菌或产乙醇梭菌。关于实施方法步骤A)的相应指导可以参见例如:
Saxena等人. Effect of trace metals on ethanol production from synthesis gas by the ethanologenic acetogen Clostridium ragsdalei. Journal ofIndustrial Microbiology & Biotechnology Volume 38, Number 4 (2011), 513-521,
Younesi等人. Ethanol and acetate production from synthesis gas via fermentation processes using anaerobic bacterium Clostridium ljungdahlii.Biochemical Engineering Journal Volume 27, Issue 2, 2005年12月15日, 第110-119页,
Sakai等人. Ethanol production from H2 and CO2 by a newly isolated thermophilic bacterium, Moorella sp. HUC22-1.Biotechnology Letters Volume 26,Number 20 (2004), 1607-1612,和
Abrini等人. Clostridium autoethanogenum, sp. nov., an anaerobic bacterium that produces ethanol from carbon monoxide. Archives of Microbiology Volume161, Number 4 (1994), 345-351。
方法步骤A)优选地在厌氧条件下进行。
在根据本发明的方法的方法步骤B)中,将在方法步骤A)中形成的乙酸盐和/或乙醇,尤其是乙酸盐与所述第一种微生物分离。
在最简单的情况中,例如通过已知方法诸如沉降、离心或过滤,将微生物作为固体从包含乙酸盐和/或乙醇、尤其是乙酸盐的培养基中除去,并任选地将剩余的液相直接供入方法步骤C)。所述直接供入具有以下优点:得自方法步骤A)的还另外包含的培养基组分(例如,维生素、痕量元素或诱导物)在方法步骤C)中同样供第二种微生物利用,并因此是优选的。在这方面,在供入到方法步骤C)之前,提高乙酸盐和/或乙醇、尤其是乙酸盐的浓度(例如通过除去至少一部分存在的水)可能是有利的且因此是优选的。
同样地,借助于萃取,尤其是借助于原位萃取,可以由方法步骤A)中的微生物除去乙酸盐本身。合适的萃取方法是本领域技术人员已知的,因而例如得自:EP2294206,WO2000014052, US 4405717, Katikaneni等人. Purification of Fermentation- Derived Acetic Acid By Liquid-Liquid Extraction and Esterification. Ind. Eng.Chem. Res. 2002, 41, 2745-2752, 和Huh等人. Selective extraction of acetic acid from the fermentation broth produced by Mannheimia succiniciproducens.Biotechnol Lett. 2004 Oct; 26(20):1581-4。
合适的萃取剂描述在例如WO2000014052的第8-17页的第A点The modified solvent and solvent/co-solvent mixture(改进的溶剂和溶剂/共溶剂混合物)下面。
在通过萃取分离乙酸盐的情况中,优选包含特别是烷基胺或低沸点溶剂诸如MTBE或乙酸乙酯作为萃取剂,其中所述烷基胺优选是具有至少16个碳原子的那些,优选是三烷基胺,且特别优选是选自三己胺、三辛胺(Trioctylamin)、三癸胺、三辛基胺(Tricaprylamin)、三-十二烷基胺的三烷基胺。这些包含三烷基胺的萃取剂优选地与原位萃取结合用在方法步骤B)中。这具有第一种微生物不受损伤的技术效果和可以在反向流方法中进行方法步骤B)的额外优点,这是另外优选的。
作为在方法步骤B)中使用的萃取剂尤其使用三辛胺和2-乙基-1-己醇的混合物,在此这些优选地以相同量使用。
关于详细的方法说明,可以参考EP2294206和那里描述的方法步骤A)和B)。
在方法步骤C)中,用第二种微生物将所述乙酸盐和/或乙醇、尤其是乙酸盐转化成烃,所述烃被至少一个含有至少一个氧原子的基团取代。
所述被至少一个含有至少一个氧原子的基团取代的烃优选是羧酸、二羧酸、羟基羧酸、羧酸酯、羟基羧酸酯、醇、醛、酮,其尤其具有4-32个、优选6-20个、特别优选8-12个碳原子。特别优选的是羧酸、羟基羧酸和羧酸酯。
所述第二种微生物优选是酵母或细菌。
所述第二种微生物优选是遗传修饰的菌株,其尤其已经在遗传上优化了被至少一个含有至少一个氧原子的基团取代的烃的收率。
本领域技术人员由现有技术知晓适合用于各自的靶分子的第二种微生物和要使用的工艺条件。
如,
WO2011127409、WO2009111672和WO2010062480描述了合适的第二种微生物和用于制备脂肪醇的方法,
WO2012017083描述了脂肪酸乙酯的制备,
WO2011157848、WO2011059745、WO 2009140695、WO2007106903和WO2009124694描述了脂肪酸的制备,
WO2010126891描述了醇、脂肪酸和脂肪酸酯的制备,
WO2010118410、WO2010021711和WO2010022090描述了脂肪酸酯的制备、
WO2010042664和WO 2009140695描述了脂肪酸醛的制备,
WO2012038390、WO2007077568和WO2011153317描述了二羧酸的制备,和
WO2011008232、WO 2009156214、WO2007141208、WO2004003213、GB2473755和EP11191923.9描述了羟基羧酸的制备。
在根据本发明的方法的一种优选替代方法中,所述被至少一个含有至少一个氧原子的基团取代的烃是脂肪酸,尤其是具有4-32个、优选6-20个、特别优选8-12个碳原子的直链饱和脂肪酸。在这种情况中,所述第二种微生物具体地是这样的微生物:其与它的野生型相比具有增加的至少一种硫酯酶的活性。术语“与它的野生型相比增加的活性”应当理解为是指:所述微生物已经经过遗传修饰,使得它具有该增加的活性。优选地,这被理解为是指硫酯酶的过表达或外源硫酯酶的表达。在这方面优选的硫酯酶选自酰基-ACP-硫酯酶,优选EC 3.1.2.14或EC 3.1.2.22或酰基辅酶A-硫酯酶,优选EC 3.1.2.2、EC 3.1.2.18、EC3.1.2.19、EC 3.1.2.20或EC 3.1.2.22。在根据本发明的替代方法中使用的优选的第二种微生物公开于WO2010118410、WO2010075483、WO2008119082和WO2007136762中,明确地参考这些文件中关于这些微生物和关于这些硫酯酶的公开内容。
在根据本发明的方法的一个特别优选的实施方案中,所述脂肪酸是辛酸和/或癸酸,且所述硫酯酶是得自萼距花(Cuphea hookeriana)的fatB2的基因产物。
在根据本发明的方法的一种优选替代方法中,所述被至少一个含有至少一个氧原子的基团取代的烃是羟基羧酸、尤其是ω-羟基羧酸,或羟基异丁酸、尤其是3-羟基异丁酸。在涉及羟基异丁酸的情况中,所述第二种微生物尤其是在WO2009156214、WO2007141208、WO2009135074和EP11191923.9中公开的微生物,明确地参考这些文件中关于这方面的公开内容。在涉及ω-羟基羧酸的情况中,所述第二种微生物尤其是在WO2011008232中公开的微生物,明确地参考该文件中关于这方面的公开内容。
根据本发明优选的是,将在方法步骤C)中产生的二氧化碳返回至方法步骤A)中的方法中,并因此用作碳源。这具有碳收率为100%的技术效果。
下面列出的实施例示例性描述本发明,没有任何意图将由整个说明书和权利要求书中给出的本发明、其应用范围限制于在实施例中提及的实施方式。
附图说明
下述附图是实施例的组成部分:
图1:在大肠杆菌(E. coli)中由乙酸盐生产脂肪酸,所述乙酸盐由微生物由合成气制备。
具体实施方式
实施例
实施例1: 方法步骤A)乙酸盐和乙醇形成
将食一氧化碳梭菌DSMZ 15243的活培养物装入1 l厌氧瓶中,每瓶含有200 ml根据Hurst由1 g酵母浸出物、19 g MES、30 ml矿物盐溶液、10 ml痕量元素溶液、10 ml维生素溶液在1 l双蒸馏水中组成的改良PETC培养基。用0.5 M NaOH将pH调至pH 5.9。每升矿物盐溶液由80 g氯化钠、100 g氯化铵、10 g氯化钾、10 g磷酸氢二钾、20 g硫酸镁、4 g氯化钙组成。每升维生素溶液由0.01 g吡多辛、0.005 g硫胺素、0.005 g核黄素、0.005 g泛酸钙、0.005 g硫辛酸、0.005 g (对)氨基苯甲酸、0.005 g烟酸、0.005 g维生素B12、0.002 g生物素、0.002 g叶酸、0.01 g美司钠组成。每升痕量元素溶液由2 g次氮基乙酸、1 g硫酸锰、0.8g硫酸铁铵、0.2 g氯化钴、0.2 g硫酸锌、0.02 g氯化铜(II)、0.02 g氯化镍、0.02 g钼酸钠、0.02 g硒酸钠、0.02 g钨酸钠组成。
将培养基煮沸20 min,然后用纯氮气通气20 min。然后将它在121℃高压灭菌20分钟。冷却后,将培养基用50%CO、45%H2和5%CO2的气体混合物供气3次,直到1巴的过压。然后将压力调至0.8巴的过压。在即将接种之前,在无菌厌氧条件下,在每种情况下加入1.5 ml的4%的亚硫酸钠/半胱氨酸盐酸盐溶液作为还原剂。
将培养物在100 upm(5 cm离心率)下在37℃培养。在每种情况下,在72小时以后,通过接种将培养物转移至新培养基。
由这样的48 h龄培养物取出用于产物制备的接种物。
为此,给2 l搅拌容器(得自Infors HT的Labfos 2)装入900 ml上述的改良PETC培养基(不包括美司钠,不含维生素溶液),并用氮气通气20分钟。然后将容器在121℃高压灭菌20分钟。然后在无菌厌氧条件下加入维生素溶液。
在整个发酵过程中,用0.5 M NaOH和0.5 M HCl将pH调在5.9。
使用得自Westphal Mess- und Regeltechnik的WMR 4000气体混合站,将气体混合物调至80%CO和20%CO2。恒定地以5 l/h进行通气。
将搅拌器速度设定在恒定的400 rpm,其相当于0.2 W/l的功率输入。
在即将接种之前,在无菌厌氧条件下,在每种情况下加入7.5 ml的4%的亚硫酸钠/半胱氨酸盐酸盐溶液作为还原剂。
接种物为10%,并且同样在无菌厌氧条件下在气化开始以后30分钟加入。起始OD600为0.055。
在0/14.4/16.8/20.8/24.2/38.7 h以后,使用注射器经由立管抽出3 ml样品。
通过高效液相色谱法(HPLC),确定乙酸、乙醇、丁酸和丁醇的浓度。使用柱AminexHPX-87H作为固定相。使用的洗脱液是5 mM硫酸,恒定流速为0.6 ml/min。柱的温度为40℃。借助于折射率检测器进行乙醇和丁醇的检测,并使用二极管阵列检测器在210 nm的波长下检测乙酸和丁酸。借助确定浓度的校准直线,经由峰面积确定物质浓度。
38.7小时以后,测得0 mM丁醇、1.42 mM丁酸盐、3.33 mM乙醇和54.26 mM乙酸盐。这相当于91.95%的乙酸盐比例。
实施例2: 方法步骤B)乙酸盐分离
分离细胞以后,通过加入乙酸,将发酵液的pH降至低于3.0的pH。然后将三正辛基胺在1-辛醇中的溶液(比率为1:1)加入发酵液中,并在25℃在至少1000 rpm的搅拌器速度下与发酵液一起混合最多2小时。随后通过离心进行相分离。然后在120℃和500毫巴的过压下由有机相中蒸馏出乙酸。通过HPLC确定馏出液的乙酸含量,并将该溶液以对应的浓度用在进一步发酵中(参见实施例3和4和6)。
实施例3:在重组大肠杆菌中将乙酸盐转化成C8和C10脂肪酸
用接种针将大肠杆菌菌株JW5020-1 (ΔfadE)(可得自Yale CGSC, The Coli GeneticStock Center)由冷冻培养物划线到LB琼脂平板(pH 7)上,所述LB琼脂平板由5 g酵母浸出物、10 g蛋白胨、0.5 g氯化钠和15 g琼脂组成。用接种针将大肠杆菌菌株JW5020-1 (ΔfadE) pJ294 [Ptac-ChFATB2_optEc]由冷冻培养物划线到LB平板上,所述LB平板另外包含100 mg/ml氨苄西林。将平板在37℃温育过夜。
用得自萼距花的基因fatB2的表达载体转化大肠杆菌菌株JW5020-1 (ΔfadE)pJ294 [Ptac-ChFATB2_optEc]。为了生产前述载体,对在大肠杆菌中用于该表达的基因进行密码子优化。将该基因与tac启动子一起合成,并且同时插入在启动子上游的限制位点和在终止子下游的限制位点。将合成的DNA片段Ptac-ChFatB2 (SEQ ID NO. 1)用限制性内切核酸酶BamHI和NotI消化,并连接进对应地切割的载体pJ294 (DNA2.0 Inc., Menlo Park,CA, USA)中。完成的大肠杆菌表达载体被称作pJ294[Ptac-ChFATB2_optEc] (SEQ ID NO.2)。
预培养1:将两种培养物分别转移接种在位于100 ml带挡板的摇瓶中的10 ml M9mod-G液体培养基中。所述M9 mod-G培养基由溶解在800 ml M9缓冲液和150 ml ddH2O中的2.6 g/l (NH4)2SO4、0.49 g/l MgSO4+7H2O、20 g/l葡萄糖、1 ml/l痕量元素US3组成。所述M9缓冲液由溶解在800 ml ddH2O中的6.79 g/l Na2HPO2+2H2O、3 g/l KH2PO4、0.5 g/l NaCl、2g/l NH4Cl组成。对于携带质粒的菌株,将100µg/ml氨苄西林加入培养基中。
在每种情况下,使用接种针将一满环的细胞材料从平板转移至相应的液体培养基中。
将培养物在37℃和200 rpm温育过夜。
20小时以后,OD为:
大肠杆菌JW5020-1 (ΔfadE) 10.6
大肠杆菌JW5020-1 (ΔfadE) pJ294[Ptac-ChFATB2_optEc] 12.8。
预培养2
将得自预培养1的0.5 ml转移接种在位于100 ml带挡板的摇瓶中的20 ml M9,mod-G中。所述M9,mod-G培养基由溶解在800 ml M9缓冲液和170 ml ddH2O中的2.6 g/l (NH4)2SO4、0.49 g/l MgSO4+7H2O、60 mM醋酸钠(得自实施例2)、1 ml/l痕量元素US3组成。对于携带质粒的菌株的培养,加入100µg/ml氨苄西林。
将培养物在37℃和200 rpm温育过夜。
预培养2的OD为
大肠杆菌JW5020-1 (ΔfadE)/乙酸盐 2.5
大肠杆菌JW5020-1 (ΔfadE) pJ294[Ptac-ChFATB2_optEc]/乙酸盐 1.75
给1000 ml带挡板的摇瓶中的100 ml改良的M9液体培养基(含有60 mM乙酸盐/菌株)接种所述预培养物,由此得到0.2的OD。
在37℃和225 rpm下温育该培养物。
在约0.5的OD600下,用1 mM IPTG(得自1M IPTG的原液)进行诱导。
为取样,在每种情况下,无菌取出4 ml细胞混悬液,确定OD,并将剩余的混悬液在15 ml falcon试管中在-80℃储存,直到对样品进行后处理。
脂肪酸的定量在衍生化为脂肪酸甲酯后借助于气相色谱法进行。在加入1 ml丙酮和2 ml水之后,将50µl十七烷酸(10 g/l,溶解在乙醇中)作为内部参比物加入由2 ml培养液组成的样品中。将样品用200µl乙酸酸化,并与10 ml的1:1 (v/v)氯仿/甲醇混合物混合。将样品剧烈混合至少1 min。然后将氯仿相取出和蒸发。将干燥的残余物溶解于1 ml的1.25M盐酸的甲醇溶液中,并在50℃温育过夜,以酯化所含脂肪酸。通过加入5 ml饱和碳酸钠溶液停止反应(所有物质得自Sigma-Aldrich, Steinheim)。通过加入1 ml正庚烷并剧烈混合15秒,萃取脂肪酸甲酯。借助于气相色谱法测量将庚烷相。为了分离脂肪酸甲酯,使用毛细管柱SPTM-2560 (Supelco, Sigma-Aldrich, Steinheim)作为固定相,所述SPTM-2560具有100 m x 0.25 mm的尺寸和0.2µm的膜厚度。使用的载体气体为氦气。历时45 min进行分离,在开始时为260℃的注射器温度、260℃的检测器温度和140℃的柱温度,保持5 min,并以4℃/min的速率增加至240℃并保持15 min。注射体积为1µl,分裂率为1:20,载体气体的流通量为1 ml/min。借助于火焰离子化检测器(GC Perkin Elmer Clarus 500, Perkin Elmer,Rodgau)进行检测。使用十七烷酸(Sigma-Aldrich, Steinheim)作为用于定量脂肪酸甲酯的内部参比物。将参比物C8:0-Me辛酸甲酯、C10:0-Me癸酸甲酯、C12:0-Me月桂酸甲酯、C14:0-Me肉豆蔻酸甲酯、C16:0-Me棕榈酸甲酯、C16:1-Me棕榈油酸甲酯、C18:0-Me硬脂酸甲酯、C18:1-Me油酸甲酯(GLC Standard Mix GLC-20 1892-1AMP, GLC-30 1893-1AMP, GLC-501894-1AMP, Sigma-Aldrich, Steinheim)用于校准。所有脂肪酸甲酯的测定限度是10 mg/l的浓度。
96小时以后,大肠杆菌JW5020-1 (ΔfadE) pJ294[Ptac-ChFATB2_optEc]的脂肪酸浓度的分布表现出标准化至1的OD,如在图1中所示。
实施例4:用解脂耶氏酵母(Yarrowia lipolytica)H222-41Δ3HIBDH (ura)-8将
乙酸盐转化成3-羟基异丁酸(3-HIB)
根据EP 11191923.9的实施例1,第1-3点,合成了具有减弱的3-羟基异丁酸脱氢酶活性的解脂耶氏酵母细胞H222-41;该细胞在下文中被称作H222-41Δ3HIBDH (ura)-8。
与对应的野生型H222-41 (ura)-8相比,培养H222-41Δ3HIBDH (ura)-8。
培养
将两种菌株用接种针由冷冻培养物无菌划线到YEPD琼脂平板上。所述YEPD琼脂平板由10 g葡萄糖、10 g酵母浸出物、20 g蛋白胨和15 g琼脂组成。pH是5.4。在25℃温育80小时。
预培养(生物质生产)
给6个1000 ml无挡板的摇瓶装入100 ml由葡萄糖、10 g酵母浸出物、20 g蛋白胨组成的YEPD液体培养基(pH 5.4)。向每个摇瓶中加入3滴Delmex消泡剂。
每种菌株各接种转移3个摇瓶,在每种情况下,用接种针无菌接种转移2满环的对应的YEPD琼脂平板的细胞材料。在28℃和180 rpm(振幅2.5 cm)下,将摇瓶温育20小时。
用于乙酸盐培养的接种物的制备
20小时以后,将3个含有解脂耶氏酵母H222-41Δ3HIBDH (ura)-8和解脂耶氏酵母H222-41 (ura)-8的摇瓶合并。使用得自KREIENBAUM Wissenschaftiche Meßsysteme e.K.的多参数生物分析体系 YSI 7100确定葡萄糖含量,为0 g/l。将所述液体培养基分入50 mlfalcon试管中,并在5600 rpm下离心10分钟。抛弃上清液,并将沉淀物再悬浮于0.9%的NaCl溶液中,并再次在5600 rpm下离心10分钟。将该操作重复另外2次,以除去可能的残余糖。然后,在每种情况下将沉淀物再悬浮于15 ml乙酸盐培养基中,并根据菌株合并培养物,并且在每种情况下用乙酸盐培养基补充至50 ml。
根据van Uden的乙酸盐培养基具有下述组成:
基础培养基
5 g/l (NH4)2SO4, 5 g/l KH2PO4, 0.5 g/l MgSO4 x 7 H2O, 0.15 g/l CaCl2 x 2H2O, 4 g/l乙酸钠(得自实施例2), 5 ml/l维生素溶液, 5 ml/l生物素溶液, 5 ml/l痕量元素溶液A, 5 ml/l痕量元素溶液B。
维生素溶液
80 mg/100 ml泛酸钙, 200 mg/100 ml肌醇, 160 mg/100 ml烟酸, 160 mg/100 ml盐酸吡哆醇, 16 mg/100 ml盐酸硫胺素。
生物素溶液
生物素8 mg/l。
痕量元素溶液A
100 mg/100 ml H3BO3, 20 mg/100 ml KI, 40 mg/100 ml NaMoO4 x 2 H2O。
痕量元素溶液B
8 mg/100 ml CuSO4 x 5 H2O, 40 mg/100 ml FeCl8 x 6 H2O, 80 mg/100 ml MnSO4x 4 H2O, ZnSO4 x 7 H2O 0.001 N HCl。
将基础培养基的固体组分溶解在700 ml ddH2O中,将pH调至5.4,并将培养基高压灭菌。将溶液无菌过滤,并在冷却后加入到基础培养基中,然后用无菌ddH2O将总培养基补至1000 ml。
调节发酵罐
给得自DASGIP的平行发酵系统的4个800 ml无菌发酵罐装入175 ml乙酸盐培养基。将工艺条件设置为30 pO2 [%]、14 sl/h空气流、400-1500 rpm搅拌器速度、28℃温度和pH5.4。用0.5%H2SO4或25%乙酸和12.5%NH4OH调节pH。使用的补料使用14%的乙酸钠溶液,pH5.4。
3-HIB的生产
给每2个发酵罐接种25 ml接种物解脂耶氏酵母H222-41Δ3HIBDH (ura)-8和解脂耶氏酵母H222-41 (ura)-8。
在接种后0、3、5、21、30和46小时进行取样。对于所有样品,用得自R-Biopharm的Analytical Test Kit,测定OD600和乙酸盐含量。使补料适应乙酸盐消耗。
对于在0和46小时的样品,另外用D2O作为溶剂进行NMR测定,并进行乙酸盐和3HIB的水抑制。
结果
OD在实验期间由平均10增加至平均45。
在开始时,乙酸盐含量为平均2250 mg/kg,在发酵结束时为32 mg/l。
对于解脂耶氏酵母H222-41Δ3HIBDH (ura)-8和解脂耶氏酵母H222-41 (ura)-8,在发酵开始时的3HIB含量为0 mg/l。
46小时以后,对于野生型解脂耶氏酵母H222-41 (ura)-8,测得0 mg/kg。
具有3-HIB脱氢酶敲除的解脂耶氏酵母菌株H222-41Δ3HIBDH (ura)-8已经产生了平均18 mg/kg 3HIB。
实施例5: 方法步骤B)乙醇分离
通过直接蒸馏得自实施例1的发酵液,以水性浓缩物的形式分离出乙醇。
实施例6:用厌氧细菌克鲁佛梭菌(Clostridium kluyveri)将乙酸盐和乙醇转化
成己酸和己酸乙酯
为进行培养,使用耐压玻璃瓶,其可以用丁基橡胶塞气密密封。所有培养步骤在厌氧条件下进行。将瓶子在121℃高压灭菌20 min,以确保无菌。
对于培养物,给4个耐压玻璃瓶(容积500 ml)装入200 ml厌氧培养基,其被DSMZ作为培养基52推荐用于克鲁佛梭菌。使用得自实施例2和5的需要的乙酸盐和乙醇。然后给培养物分别接种10 ml克鲁佛梭菌的培养物。将培养物分别用丁基橡胶塞密封,在35°温育116.25 h。在培养开始和结束时取样。研究它们的光密度并借助NMR研究不同的分析物。由于借助于NMR仅可以将己酸和己酸乙酯确定为累积参数,因此借助于GC/MS分析来确认两种物质各自在最终样品中的存在。
经培养持续时间,平均经过4轮重复,显示出乙酸盐由5.4 g/l下降至1.4 g/l,且乙醇由14.2 g/l下降至5.8 g/l。同时,可证明丁酸的形成;在这里,值由0.13 g/l增加至2.5 g/l,和己酸/己酸乙酯的形成;在这里,总值由0.05 g/l增加至7.6 g/l。
序列表
<110> 赢创运营有限公司
<120> 使用合成气的多级合成方法
<130> 201100374
<160> 2
<170> PatentIn 3.5版
<210> 1
<211> 1143
<212> DNA
<213> 人工序列
<220>
<223> 经过密码子优化的基因
<400> 1
gcggccgcaa attcagtaag cagaaagtca aaagcctccg accggaggct tttgactatt 60
aggaaacgct gttgccatta gacgtcttgc cggtgctaat agcaccattc gcacctgcat 120
ttttcggacg ccactcggtt gcaccattga cgattgcagt accatcctcc agacgcagca 180
ggtgttgata ttggctacgc acaccaactt tggacgggtc catcgccgtc acgctttcca 240
aaacgctgtc acggccgcac tcgcgacgat attccagagc caggctgcac agctcctgcg 300
tttccaggac ctcggtcggc atgctctcca gaatccagcc aatgtatttg acgttgctga 360
catgttgatt cacatccaga tcgttccagc ctggggtcaa gcctttttgg atgctgtcac 420
cggtcttaac cttgaactta tggaccttca gatcgctatc ctcgataacc ggagagtcaa 480
cgaacagagg gacgatttcc tgatgcacct cgtacggcag cttgctcagg cgacgagttt 540
tctgattcat catggcatac gcgctggtcg cacgcaccag gatttcgccc gtattgcaat 600
cgctaatcag ccagtcgcga cccataccaa tcttacccag acggctgaaa cgcgtgttaa 660
tctcaacggt gtcaccccag gccgggtaac ggttaacttt gatctgcatc ttaatcacca 720
cccaaatcaa atcacgctta cacatctcca gggtgcgacc gaaaccatcc aacaggatac 780
cggtagattt acagtggttc aagctggttt cctgcaggtg gttcatcagg gtttcgatgc 840
tcgcggtacg atccgtgcca atctcgtagc tgcggatgct aaaggattga cgaaacacca 900
ggccgtcctg gaccgtgctt tccagaccaa acgagtctac cagcatgtcc gggcgtttgg 960
atttgcggtc gtgcatatgt tttacctcct gttaaacaaa attatttcta gagggaaacc 1020
gttgtggaat tgtgagcgct cacaattcca catccacaca ttatacgagc cgatgattaa 1080
ttgtcaacag cgtcgatcac tgtgcatgaa gctcgtaatt gttatccgct cacaattgga 1140
tcc 1143
<210> 2
<211> 4985
<212> DNA
<213> 人工序列
<220>
<223> 载体
<400> 2
accaatgctt aatcagtgag gcacctatct cagcgatctg tctatttcgt tcatccatag 60
ttgcctgact ccccgtcgtg tagataacta cgatacggga gggcttacca tctggcccca 120
gcgctgcgat gataccgcga gaaccacgct caccggctcc ggatttatca gcaataaacc 180
agccagccgg aagggccgag cgcagaagtg gtcctgcaac tttatccgcc tccatccagt 240
ctattaattg ttgccgggaa gctagagtaa gtagttcgcc agttaatagt ttgcgcaacg 300
ttgttgccat cgctacaggc atcgtggtgt cacgctcgtc gtttggtatg gcttcattca 360
gctccggttc ccaacgatca aggcgagtta catgatcccc catgttgtgc aaaaaagcgg 420
ttagctcctt cggtcctccg atcgttgtca gaagtaagtt ggccgcagtg ttatcactca 480
tggttatggc agcactgcat aattctctta ctgtcatgcc atccgtaaga tgcttttctg 540
tgactggtga gtactcaacc aagtcattct gagaatagtg tatgcggcga ccgagttgct 600
cttgcccggc gtcaatacgg gataataccg cgccacatag cagaacttta aaagtgctca 660
tcattggaaa acgttcttcg gggcgaaaac tctcaaggat cttaccgctg ttgagatcca 720
gttcgatgta acccactcgt gcacccaact gatcttcagc atcttttact ttcaccagcg 780
tttctgggtg agcaaaaaca ggaaggcaaa atgccgcaaa aaagggaata agggcgacac 840
ggaaatgttg aatactcata ttcttccttt ttcaatatta ttgaagcatt tatcagggtt 900
attgtctcat gagcggatac atatttgaat gtatttagaa aaataaacaa ataggggtca 960
gtgttacaac caattaacca attctgaaca ttatcgcgag cccatttata cctgaatatg 1020
gctcataaca ccccttgttt gcctggcggc agtagcgcgg tggtcccacc tgaccccatg 1080
ccgaactcag aagtgaaacg ccgtagcgcc gatggtagtg tggggactcc ccatgcgaga 1140
gtagggaact gccaggcatc aaataaaacg aaaggctcag tcgaaagact gggcctttcg 1200
cccgggctaa ttatggggtg tcgcccttat tcgactctat agtgaagttc ctattctcta 1260
gaaagtatag gaacttctga agtgggggcg gccgcaaatt cagtaagcag aaagtcaaaa 1320
gcctccgacc ggaggctttt gactattagg aaacgctgtt gccattagac gtcttgccgg 1380
tgctaatagc accattcgca cctgcatttt tcggacgcca ctcggttgca ccattgacga 1440
ttgcagtacc atcctccaga cgcagcaggt gttgatattg gctacgcaca ccaactttgg 1500
acgggtccat cgccgtcacg ctttccaaaa cgctgtcacg gccgcactcg cgacgatatt 1560
ccagagccag gctgcacagc tcctgcgttt ccaggacctc ggtcggcatg ctctccagaa 1620
tccagccaat gtatttgacg ttgctgacat gttgattcac atccagatcg ttccagcctg 1680
gggtcaagcc tttttggatg ctgtcaccgg tcttaacctt gaacttatgg accttcagat 1740
cgctatcctc gataaccgga gagtcaacga acagagggac gatttcctga tgcacctcgt 1800
acggcagctt gctcaggcga cgagttttct gattcatcat ggcatacgcg ctggtcgcac 1860
gcaccaggat ttcgcccgta ttgcaatcgc taatcagcca gtcgcgaccc ataccaatct 1920
tacccagacg gctgaaacgc gtgttaatct caacggtgtc accccaggcc gggtaacggt 1980
taactttgat ctgcatctta atcaccaccc aaatcaaatc acgcttacac atctccaggg 2040
tgcgaccgaa accatccaac aggataccgg tagatttaca gtggttcaag ctggtttcct 2100
gcaggtggtt catcagggtt tcgatgctcg cggtacgatc cgtgccaatc tcgtagctgc 2160
ggatgctaaa ggattgacga aacaccaggc cgtcctggac cgtgctttcc agaccaaacg 2220
agtctaccag catgtccggg cgtttggatt tgcggtcgtg catatgtttt acctcctgtt 2280
aaacaaaatt atttctagag ggaaaccgtt gtggaattgt gagcgctcac aattccacat 2340
ccacacatta tacgagccga tgattaattg tcaacagcgt cgatcactgt gcatgaagct 2400
cgtaattgtt atccgctcac aattggatcc aaaatgaagg gaagttccta tactttctag 2460
agaataggaa cttctatagg gagtcgaata agggcgacac aaaaggtatt ctaaatgcat 2520
aataaatact gataacatct tatagtttgt attatatttt gtattatcgt tgacatgtat 2580
aattttgata tcaaaaactg attttccctt tattattttc gagatttatt ttcttaattc 2640
tctttaacaa actagaaata ttgtatatac aaaaaatcat aaataataga tgaatagttt 2700
aattataggt gttcatcaat cgaaaaagca acgtatctta tttaaagtgc gttgcttttt 2760
tctcatttat aaggttaaat aattctcata tatcaagcaa agtgacaggc gcccttaaat 2820
attctgacaa atgctctttc cctaaactcc ccccataaaa aaacccgccg aagcgggttt 2880
ttacgttatt tgcggattaa cgattactcg ttatcagaac cgcccaggat gcctggcagt 2940
tccctactct cgccgctgcg ctcggtcgtt cggctgcggg acctcagcgc tagcggagtg 3000
tatactggct tactatgttg gcactgatga gggtgtcagt gaagtgcttc atgtggcagg 3060
agaaaaaagg ctgcaccggt gcgtcagcag aatatgtgat acaggatata ttccgcttcc 3120
tcgctcactg actcgctacg ctcggtcgtt cgactgcggc gagcggaaat ggcttacgaa 3180
cggggcggag atttcctgga agatgccagg aagatactta acagggaagt gagagggccg 3240
cggcaaagcc gtttttccat aggctccgcc cccctgacaa gcatcacgaa atctgacgct 3300
caaatcagtg gtggcgaaac ccgacaggac tataaagata ccaggcgttt ccccctggcg 3360
gctccctcgt gcgctctcct gttcctgcct ttcggtttac cggtgtcatt ccgctgttat 3420
ggccgcgttt gtctcattcc acgcctgaca ctcagttccg ggtaggcagt tcgctccaag 3480
ctggactgta tgcacgaacc ccccgttcag tccgaccgct gcgccttatc cggtaactat 3540
cgtcttgagt ccaacccgga aagacatgca aaagcaccac tggcagcagc cactggtaat 3600
tgatttagag gagttagtct tgaagtcatg cgccggttaa ggctaaactg aaaggacaag 3660
ttttggtgac tgcgctcctc caagccagtt acctcggttc aaagagttgg tagctcagag 3720
aaccttcgaa aaaccgccct gcaaggcggt tttttcgttt tcagagcaag agattacgcg 3780
cagaccaaaa cgatctcaag aagatcatct tattaatcac tgcccgcttt ccagtcggga 3840
aacctgtcgt gccagctgca ttaatgaatc ggccaacgcg cggggagagg cggtttgcgt 3900
attgggcgcc agggtggttt ttcttttcac cagtgagact ggcaacagct gattgccctt 3960
caccgcctgg ccctgagaga gttgcagcaa gcggtccacg ctggtttgcc ccagcaggcg 4020
aaaatcctgt ttgatggtgg ttaacggcgg gatataacat gagctatctt cggtatcgtc 4080
gtatcccact accgagatat ccgcaccaac gcgcagcccg gactcggtaa tggcgcgcat 4140
tgcgcccagc gccatctgat cgttggcaac cagcatcgca gtgggaacga tgccctcatt 4200
cagcatttgc atggtttgtt gaaaaccgga catggcactc cagtcgcctt cccgttccgc 4260
tatcggctga atttgattgc gagtgagata tttatgccag ccagccagac gcagacgcgc 4320
cgagacagaa cttaatgggc ccgctaacag cgcgatttgc tggtgaccca atgcgaccag 4380
atgctccacg cccagtcgcg taccgtcctc atgggagaaa ataatactgt tgatgggtgt 4440
ctggtcagag acatcaagaa ataacgccgg aacattagtg caggcagctt ccacagcaat 4500
ggcatcctgg tcatccagcg gatagttaat gatcagccca ctgacgcgtt gcgcgagaag 4560
attgtgcacc gccgctttac aggcttcgac gccgcttcgt tctaccatcg acaccaccac 4620
gctggcaccc agttgatcgg cgcgagattt aatcgccgcg acaatttgcg acggcgcgtg 4680
cagggccaga ctggaggtgg caacgccaat cagcaacgac tgtttgcccg ccagttgttg 4740
tgccacgcgg ttgggaatgt aattcagctc cgccatcgcc gcttccactt tttcccgcgt 4800
tttcgcagaa acgtggctgg cctggttcac cacgcgggaa acggtctgat aagagacacc 4860
ggcatactct gcgacatcgt ataacgttac tggtttcata ttcaccaccc tgaattgact 4920
ctcttccggg cgctatcatg ccataccgcg aaaggttttg cgccattcga tggcgcgccg 4980
ctttt 4985
Claims (12)
1.制备烃的方法,所述烃被至少一个含有至少一个氧原子的基团取代,所述方法包括以下方法步骤:
A) 用第一种微生物将碳源转化成乙酸盐和/或乙醇,所述碳源包含选自CO2和CO的至少一种,
B) 将所述第一种微生物与所述乙酸盐和/或乙醇分离,
C) 用第二种微生物将所述乙酸盐和/或乙醇转化成烃,所述烃被至少一个含有至少一个氧原子的基团取代,和任选地
D) 纯化所述被至少一个含有至少一个氧原子的基团取代的烃。
2.根据权利要求2所述的方法,其特征在于,方法步骤A)中的碳源包含基于在方法步骤A)中所述微生物可利用的所有碳源计至少50重量%、优选至少70重量%、特别优选至少90重量%的CO2和/或CO。
3.根据权利要求1或2所述的方法,其特征在于,方法步骤A)中的碳源包含合成气,尤其是由合成气组成。
4.根据前述权利要求中的至少一项所述的方法,其特征在于,所述第一种微生物是产乙酸微生物。
5.根据前述权利要求中的至少一项所述的方法,其特征在于,所述第一种微生物选自:Clostridium autothenogenum DSMZ 19630、拉氏梭菌(Clostridium ragsdahlei)ATCC no. BAA-622、产乙醇梭菌(Clostridium autoethanogenum)、穆尔氏菌属(Moorella sp)HUC22-1、热醋穆尔氏菌(Moorella thermoaceticum)、热自养穆尔氏菌(Moorella thermoautotrophica)、Rumicoccus productus、Acetoanaerobum、普氏产醋杆菌(Oxobacter pfennigii)、巴氏甲烷八叠球菌(Methanosarcina barkeri)、噬乙酸甲烷八叠球菌(Methanosarcina acetivorans)、氧化碳嗜热菌属(Carboxydothermus)、Desulphotomaculum kutznetsovii、热球菌属(Pyrococcus)、消化链球菌属(Peptostreptococcus)、食甲基丁酸杆菌(Butyribacterium methylotrophicum)ATCC 33266、蚁酸醋酸梭菌(Clostridium formicoaceticum)、酪酸梭菌(Clostridium butyricum)、Laktobacillus delbrukii、Propionibacterium acidoprprionici、Proprionispera arboris、Anaerobierspirillum succiniproducens、Bacterioides amylophilus、Becterioides ruminicola、凯伍热厌氧杆菌(Thermoanaerobacter kivui)、伍氏醋酸杆菌(Acetobacterium woodii)、潮湿厌氧醋酸菌(Acetoanaerobium notera)、醋酸梭菌(Clostridium aceticum)、食甲基丁酸杆菌(Butyribacterium methylotrophicum)、热醋穆尔氏菌(Moorella thermoacetica)、产粘真杆菌(Eubacterium limosum)、产生消化链球菌(Peptostreptococcus productus)、扬氏梭菌(Clostridium ljungdahlii)、梭菌属(Clostridium)ATCC 29797和食一氧化碳梭菌(Clostridium carboxidivorans)。
6.根据前述权利要求中的至少一项所述的方法,其特征在于,在方法步骤B)中,通过沉降、离心或过滤,由包含乙酸盐和/或乙醇的培养基中除去所述第一种微生物。
7.根据前述权利要求中的至少一项所述的方法,其特征在于,在方法步骤B)中,借助于萃取,尤其是借助于原位萃取,优选地使用包含烷基胺的萃取剂,除去乙酸盐。
8.根据权利要求7所述的方法,其特征在于,所述烷基胺选自三己胺、三辛胺(Trioctylamin)、三癸胺、三辛基胺(Tricaprylamin)和三-十二烷基胺。
9.根据前述权利要求中的至少一项所述的方法,其特征在于,在方法步骤C)中,将所述乙酸盐和/或乙醇转化成烃,所述烃被至少一个含有至少一个氧原子的基团取代,所述烃选自羧酸、二羧酸、羟基羧酸、羧酸酯、羟基羧酸酯、醇、醛、酮。
10.根据前述权利要求中的至少一项所述的方法,其特征在于,在方法步骤C)中,将所述乙酸盐和/或乙醇转化成脂肪酸,且所述第二种微生物与它的野生型相比具有增加的至少一种硫酯酶的活性。
11.根据权利要求1-9中的至少一项所述的方法,其特征在于,在方法步骤C)中,将所述乙酸盐和/或乙醇转化成羟基羧酸,尤其是转化成ω-羟基羧酸或羟基异丁酸。
12.根据前述权利要求中的至少一项所述的方法,其特征在于,将在方法步骤C)中形成的二氧化碳再返回至方法步骤A)中的方法中。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102012207921.1 | 2012-05-11 | ||
| DE201210207921 DE102012207921A1 (de) | 2012-05-11 | 2012-05-11 | Mehrstufiges Syntheseverfahren mit Synthesegas |
| CN201380024696.5A CN104271751A (zh) | 2012-05-11 | 2013-05-08 | 使用合成气的多级合成方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201380024696.5A Division CN104271751A (zh) | 2012-05-11 | 2013-05-08 | 使用合成气的多级合成方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111850053A true CN111850053A (zh) | 2020-10-30 |
Family
ID=48607211
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010735971.6A Pending CN111850053A (zh) | 2012-05-11 | 2013-05-08 | 使用合成气的多级合成方法 |
| CN201380024696.5A Pending CN104271751A (zh) | 2012-05-11 | 2013-05-08 | 使用合成气的多级合成方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201380024696.5A Pending CN104271751A (zh) | 2012-05-11 | 2013-05-08 | 使用合成气的多级合成方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10787688B2 (zh) |
| EP (1) | EP2847340A2 (zh) |
| KR (1) | KR102180340B1 (zh) |
| CN (2) | CN111850053A (zh) |
| BR (1) | BR112014029571B1 (zh) |
| CA (1) | CA2872914C (zh) |
| DE (1) | DE102012207921A1 (zh) |
| MX (1) | MX2014013670A (zh) |
| WO (1) | WO2013167663A2 (zh) |
| ZA (1) | ZA201409014B (zh) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2602328A1 (de) * | 2011-12-05 | 2013-06-12 | Evonik Industries AG | Verfahren zur Oxidation von Alkanen unter Verwendung einer AlkB Alkan 1-Monooxygenase |
| EP2631298A1 (en) | 2012-02-22 | 2013-08-28 | Evonik Industries AG | Biotechnological method for producing butanol and butyric acid |
| DE102012207921A1 (de) | 2012-05-11 | 2013-11-14 | Evonik Industries Ag | Mehrstufiges Syntheseverfahren mit Synthesegas |
| EP2759598A1 (de) | 2013-01-24 | 2014-07-30 | Evonik Industries AG | Verfahren zur Herstellung von alpha, omega-Alkandiol |
| EP2944696A1 (en) | 2014-05-13 | 2015-11-18 | Evonik Degussa GmbH | Method of producing organic compounds |
| EP2944697A1 (en) * | 2014-05-13 | 2015-11-18 | Evonik Degussa GmbH | Method of producing nylon |
| EP3050967A1 (en) * | 2015-01-28 | 2016-08-03 | Evonik Degussa GmbH | A method of producing higher alcohols |
| EP3050966A1 (en) | 2015-01-28 | 2016-08-03 | Evonik Degussa GmbH | An aerobic method of producing alcohols |
| CN105087441B (zh) * | 2015-08-20 | 2018-11-30 | 安徽省中科通源环境科技有限公司 | 一种复合菌群及其在合成气发酵产醇中的应用 |
| US11174496B2 (en) | 2015-12-17 | 2021-11-16 | Evonik Operations Gmbh | Genetically modified acetogenic cell |
| US11124813B2 (en) | 2016-07-27 | 2021-09-21 | Evonik Operations Gmbh | N-acetyl homoserine |
| US11649472B2 (en) * | 2017-06-30 | 2023-05-16 | Massachusetts Institute Of Technology | Controlling metabolism by substrate cofeeding |
| KR102678516B1 (ko) * | 2018-02-15 | 2024-06-27 | 에보니크 오퍼레이션즈 게엠베하 | 알칸산의 추출 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008115080A1 (en) * | 2007-03-19 | 2008-09-25 | Lanzatech New Zealand Limited | Alcohol production process |
| WO2010127318A2 (en) * | 2009-05-01 | 2010-11-04 | The Regents Of The University Of California | Product of fatty acid esters from biomass polymers |
| CN102203267A (zh) * | 2008-08-25 | 2011-09-28 | 代谢探索者公司 | 2-羟基异丁酸(2-hiba)的酶法产生 |
Family Cites Families (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4405717A (en) | 1981-10-26 | 1983-09-20 | Cpc International Inc. | Recovery of acetic acid from a fermentation broth |
| US4720457A (en) | 1984-12-20 | 1988-01-19 | Canadian Patents And Development Ltd. | Selective production of ethyl acetate and acetaldehyde by microorganisms |
| US5807722A (en) | 1992-10-30 | 1998-09-15 | Bioengineering Resources, Inc. | Biological production of acetic acid from waste gases with Clostridium ljungdahlii |
| UA72220C2 (uk) | 1998-09-08 | 2005-02-15 | Байоенджініерінг Рісорсиз, Інк. | Незмішувана з водою суміш розчинник/співрозчинник для екстрагування оцтової кислоти, спосіб одержання оцтової кислоти (варіанти), спосіб анаеробного мікробного бродіння для одержання оцтової кислоти (варіанти), модифікований розчинник та спосіб його одержання |
| CA2372495C (en) | 1999-05-07 | 2010-03-09 | Bioengineering Resources, Inc. | Clostridium strains which produce ethanol from substrate-containing gases |
| US6519771B1 (en) | 1999-12-14 | 2003-02-11 | Steven Ericsson Zenith | System for interactive chat without a keyboard |
| EP1350788A3 (de) | 2002-03-28 | 2003-11-12 | Degussa AG | Verfahren zur Herstellung von Hexamethylendiamin aus Butadien |
| EP1538215B1 (en) | 2002-06-28 | 2014-11-12 | Takasago International Corporation | Processes for producing lactone |
| WO2007077568A1 (en) | 2005-12-30 | 2007-07-12 | Council Of Scientific And Industrial Research | Process for preparing long-chain dicarboxylic acids |
| MX339812B (es) | 2006-03-15 | 2016-06-08 | Dsm Ip Assets B V * | Produccion de acido graso poli-insaturado en organismos heterologos usando sistemas de sintasa de policetido pufa. |
| DE102006017760A1 (de) | 2006-03-24 | 2007-09-27 | Ufz-Umweltforschungszentrum Leipzig-Halle Gmbh | Verfahren zur enzymatischen Herstellung von 2-Hydroxy-2-methylcarbonsäuren |
| US8110670B2 (en) * | 2006-05-19 | 2012-02-07 | Ls9, Inc. | Enhanced production of fatty acid derivatives |
| ES2763624T3 (es) | 2006-05-19 | 2020-05-29 | Genomatica Inc | Producción de ácidos grasos y derivados de los mismos |
| US20070275447A1 (en) | 2006-05-25 | 2007-11-29 | Lewis Randy S | Indirect or direct fermentation of biomass to fuel alcohol |
| DE102006025821A1 (de) | 2006-06-02 | 2007-12-06 | Degussa Gmbh | Ein Enzym zur Herstellung von Mehylmalonatsemialdehyd oder Malonatsemialdehyd |
| US7704723B2 (en) | 2006-08-31 | 2010-04-27 | The Board Of Regents For Oklahoma State University | Isolation and characterization of novel clostridial species |
| EP2594633A1 (en) | 2007-03-28 | 2013-05-22 | LS9, Inc. | Enhanced production of fatty acid derivatives |
| DE102007027006A1 (de) | 2007-06-08 | 2008-12-11 | Evonik Degussa Gmbh | Mikrobiologische Herstellung von Aldehyden, insbesondere von 3-Hydroxypropionaldehyd |
| DE102007041862A1 (de) | 2007-09-03 | 2009-03-19 | Evonik Degussa Gmbh | Mikrobiologische Herstellung von Isoprenoiden |
| NZ560757A (en) * | 2007-10-28 | 2010-07-30 | Lanzatech New Zealand Ltd | Improved carbon capture in microbial fermentation of industrial gases to ethanol |
| SG186646A1 (en) * | 2007-12-13 | 2013-01-30 | Glycos Biotechnologies Inc | Microbial conversion of oils and fatty acids to high-value chemicals |
| DE102007060705A1 (de) | 2007-12-17 | 2009-06-18 | Evonik Degussa Gmbh | ω-Aminocarbonsäuren oder ihre Lactame, herstellende, rekombinante Zellen |
| CN101990576A (zh) * | 2008-02-07 | 2011-03-23 | 齐凯姆公司 | 丁醇和己醇的间接制造 |
| EP2262901B1 (en) | 2008-03-05 | 2018-11-21 | Genomatica, Inc. | Primary alcohol producing organisms |
| EP2108702A1 (en) | 2008-04-07 | 2009-10-14 | Organo Balance GmbH | Synthesis of polyunsaturated fatty acids in yeast |
| AU2009242615A1 (en) | 2008-05-01 | 2009-11-05 | Genomatica, Inc. | Microorganisms for the production of methacrylic acid |
| EP2283121B1 (en) | 2008-05-16 | 2015-02-11 | REG Life Sciences, LLC | Methods and compositions for producing hydrocarbons |
| DE102008002715A1 (de) | 2008-06-27 | 2009-12-31 | Evonik Röhm Gmbh | 2-Hydroxyisobuttersäure produzierende rekombinante Zelle |
| DE102008040193A1 (de) * | 2008-07-04 | 2010-01-07 | Evonik Röhm Gmbh | Verfahren zur Herstellung freier Carbonsäuren |
| DE102008040415A1 (de) | 2008-07-15 | 2010-01-21 | Evonik Röhm Gmbh | Thermisches Salzspalten von Ammoniumcarboxylaten |
| WO2010021711A1 (en) | 2008-08-18 | 2010-02-25 | Ls9, Inc. | Systems and methods for the production of mixed fatty esters |
| CA2738938C (en) | 2008-10-07 | 2019-04-30 | Ls9, Inc. | Methods and compositions for producing fatty aldehydes |
| BRPI0920010A2 (pt) | 2008-10-28 | 2016-04-19 | Ls9 Inc | métodos para produzir álcool graxo e surfactante |
| MX368526B (es) | 2008-12-23 | 2019-10-07 | Reg Life Sciences Llc | Metodos y composiciones relacionados con tioesterasa enzima. |
| EP2449120A4 (en) | 2009-04-01 | 2013-11-20 | Xylofuel Llc | PROCESS FOR PRODUCING ORGANIC COMPOUNDS FROM SYNTHETIC GASES |
| WO2010118410A1 (en) | 2009-04-10 | 2010-10-14 | Ls9, Inc. | Production of fatty acid derivatives |
| CA2759273C (en) | 2009-04-27 | 2018-01-09 | Ls9, Inc. | Production of fatty acid esters |
| DE102009002811A1 (de) | 2009-05-05 | 2010-11-11 | Evonik Degussa Gmbh | Enzymatisches Verfahren zur Herstellung von Aldehyden |
| US8158391B2 (en) | 2009-05-06 | 2012-04-17 | Dna Twopointo, Inc. | Production of an α-carboxyl-ω-hydroxy fatty acid using a genetically modified Candida strain |
| EP2480673B1 (en) | 2009-09-27 | 2018-05-23 | OPX Biotechnologies, Inc. | Method for producing 3-hydroxypropionic acid and other products |
| WO2011059745A1 (en) | 2009-10-28 | 2011-05-19 | The Arizona Board Of Regents For And On Behalf Of Arizona State University | Bacterium for production of fatty acids |
| DE102009046626A1 (de) | 2009-11-11 | 2011-05-12 | Evonik Degussa Gmbh | Candida tropicalis Zellen und deren Verwendung |
| US20110250663A1 (en) | 2010-04-08 | 2011-10-13 | Ls9, Inc. | Methods and compositions related to fatty alcohol biosynthetic enzymes |
| DE102010015807A1 (de) | 2010-04-20 | 2011-10-20 | Evonik Degussa Gmbh | Biokatalytisches Oxidationsverfahren mit alkL-Genprodukt |
| BR112012027464A2 (pt) | 2010-06-04 | 2019-09-24 | Novozymes Inc | célula hospedeira, método para produzir um ácido dicarboxílico c4, e, método para aumentar a produção de ácido dicarboxílico c4. |
| WO2011157573A2 (de) | 2010-06-14 | 2011-12-22 | Evonik Röhm Gmbh | Ein enzym zur herstellung von methylmalonatsemialdehyd |
| CN103080305B (zh) | 2010-06-18 | 2014-12-24 | 丹麦科技大学 | 酵母由木质纤维素和甘油生产生物柴油 |
| DK2601292T3 (en) | 2010-08-06 | 2018-07-16 | Biopetrolia Ab | METHODS AND PRODUCTS FOR MANUFACTURING GROWERS |
| EP2606138A2 (en) | 2010-08-19 | 2013-06-26 | Lanzatech New Zealand Limited | A process for producing chemicals using microbial fermentation of substrates comprising carbon monoxide |
| BR112013006883A2 (pt) | 2010-09-24 | 2016-06-07 | Dsm Ip Assets Bv | processo de produção de ácido dicarboxílico |
| EP2557176A1 (en) | 2011-06-15 | 2013-02-13 | Evonik Degussa GmbH | Enzymatic amination |
| CA2842000A1 (en) | 2011-07-20 | 2013-01-24 | Evonik Degussa Gmbh | Oxidation and amination of primary alcohols |
| BR112014002732A8 (pt) | 2011-08-05 | 2017-06-20 | Evonik Degussa Gmbh | oxidação e aminação de álcoois secundários |
| DE102011110945A1 (de) * | 2011-08-15 | 2013-02-21 | Evonik Degussa Gmbh | Biotechnologisches Syntheseverfahren von organischen Verbindungen mit alkIL-Genprodukt |
| DE102011110946A1 (de) | 2011-08-15 | 2016-01-21 | Evonik Degussa Gmbh | Biotechnologisches Syntheseverfahren von omegafunktionalisierten Carbonsäuren und Carbonsäure-Estern aus einfachen Kohlenstoffquellen |
| EP2602328A1 (de) | 2011-12-05 | 2013-06-12 | Evonik Industries AG | Verfahren zur Oxidation von Alkanen unter Verwendung einer AlkB Alkan 1-Monooxygenase |
| EP2602329A1 (de) * | 2011-12-05 | 2013-06-12 | Evonik Degussa GmbH | Biotechnologische Herstellung von 3-Hydroxyisobuttersäure |
| EP2607490A1 (de) | 2011-12-22 | 2013-06-26 | Evonik Industries AG | Verfahren zur verbesserten Abtrennung einer hydrophoben organischen Lösung von einem wässrigen Kulturmedium |
| EP2607479A1 (en) | 2011-12-22 | 2013-06-26 | Evonik Industries AG | Biotechnological production of alcohols and derivatives thereof |
| EP2620504A1 (en) | 2012-01-25 | 2013-07-31 | Evonik Industries AG | Process for oxidizing alkenes employing the Pseudomonas putida GPo1 AlkB monooxygenase |
| EP2631298A1 (en) | 2012-02-22 | 2013-08-28 | Evonik Industries AG | Biotechnological method for producing butanol and butyric acid |
| EP2639308A1 (de) | 2012-03-12 | 2013-09-18 | Evonik Industries AG | Enzymatische omega-Oxidation und -Aminierung von Fettsäuren |
| EP2647696A1 (de) | 2012-04-02 | 2013-10-09 | Evonik Degussa GmbH | Verfahren zur aeroben Herstellung von Alanin oder einer unter Verbrauch von Alanin entstehenden Verbindung |
| EP2653538A1 (de) | 2012-04-20 | 2013-10-23 | Evonik Industries AG | NADP-abhängige Alanindehydrogenase |
| DE102012207921A1 (de) | 2012-05-11 | 2013-11-14 | Evonik Industries Ag | Mehrstufiges Syntheseverfahren mit Synthesegas |
| EP2674489A1 (en) | 2012-06-15 | 2013-12-18 | Evonik Industries AG | Biotechnological 2-hydroxyisobutyric acid production |
| EP2733215A1 (en) | 2012-11-20 | 2014-05-21 | Evonik Industries AG | Process for producing alpha,omega-diols from alkanes or 1-alkanols employing a CYP153 alkane hydroxylase |
| EP2746397A1 (de) | 2012-12-21 | 2014-06-25 | Evonik Industries AG | Herstellung von Omega-Aminofettsäuren |
| EP2759598A1 (de) | 2013-01-24 | 2014-07-30 | Evonik Industries AG | Verfahren zur Herstellung von alpha, omega-Alkandiol |
| DE102013202106A1 (de) | 2013-02-08 | 2014-08-14 | Evonik Industries Ag | Autotrophe Kultivierung |
-
2012
- 2012-05-11 DE DE201210207921 patent/DE102012207921A1/de not_active Withdrawn
-
2013
- 2013-05-08 CA CA2872914A patent/CA2872914C/en active Active
- 2013-05-08 CN CN202010735971.6A patent/CN111850053A/zh active Pending
- 2013-05-08 WO PCT/EP2013/059608 patent/WO2013167663A2/de not_active Ceased
- 2013-05-08 BR BR112014029571-9A patent/BR112014029571B1/pt not_active IP Right Cessation
- 2013-05-08 KR KR1020147031243A patent/KR102180340B1/ko active Active
- 2013-05-08 MX MX2014013670A patent/MX2014013670A/es unknown
- 2013-05-08 EP EP13728123.4A patent/EP2847340A2/de not_active Withdrawn
- 2013-05-08 US US14/400,379 patent/US10787688B2/en active Active
- 2013-05-08 CN CN201380024696.5A patent/CN104271751A/zh active Pending
-
2014
- 2014-12-09 ZA ZA2014/09014A patent/ZA201409014B/en unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008115080A1 (en) * | 2007-03-19 | 2008-09-25 | Lanzatech New Zealand Limited | Alcohol production process |
| CN102203267A (zh) * | 2008-08-25 | 2011-09-28 | 代谢探索者公司 | 2-羟基异丁酸(2-hiba)的酶法产生 |
| WO2010127318A2 (en) * | 2009-05-01 | 2010-11-04 | The Regents Of The University Of California | Product of fatty acid esters from biomass polymers |
Non-Patent Citations (2)
| Title |
|---|
| S. SAKAI 等: ""Ethanol production from H2 and CO2 by a newly isolated thermophilic bacterium, Moorella sp. HUC22-1"", 《BIOTECHNOLOGY LETTERSE》, vol. 26, pages 1607 - 1612 * |
| 陈坚 等: "《环境生物技术》", vol. 1, 中国轻工业出版社, pages: 438 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US20150125912A1 (en) | 2015-05-07 |
| MX2014013670A (es) | 2015-09-04 |
| DE102012207921A1 (de) | 2013-11-14 |
| US10787688B2 (en) | 2020-09-29 |
| WO2013167663A3 (de) | 2014-01-23 |
| EP2847340A2 (de) | 2015-03-18 |
| BR112014029571A2 (pt) | 2017-06-27 |
| WO2013167663A2 (de) | 2013-11-14 |
| ZA201409014B (en) | 2016-03-30 |
| KR20150016231A (ko) | 2015-02-11 |
| CA2872914C (en) | 2022-01-11 |
| BR112014029571B1 (pt) | 2022-02-01 |
| CA2872914A1 (en) | 2013-11-14 |
| KR102180340B1 (ko) | 2020-11-18 |
| CN104271751A (zh) | 2015-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102180340B1 (ko) | 합성 가스를 이용한 다단계 합성 방법 | |
| KR101312107B1 (ko) | 미생물 알콜 생산 방법 | |
| Danner et al. | Biotechnology for the production of commodity chemicals from biomass | |
| KR101317447B1 (ko) | 알코올 제조 방법 | |
| KR102646082B1 (ko) | 고급 알콜의 생산 방법 | |
| US20080293125A1 (en) | Engineered microorganisms for producing isopropanol | |
| KR102569875B1 (ko) | 알콜의 호기성 생산 방법 | |
| WO2012131627A1 (en) | A fermentation process for controlling butanediol production | |
| KR20120055549A (ko) | 알코올 제조방법 | |
| AU2008308477A1 (en) | Biofuel production | |
| US8119844B2 (en) | Alcohol production process | |
| JP2019525761A (ja) | 好気的条件下でアルコールを生成する工程及びオレイルアルコールを用いた生成物の抽出 | |
| KR20170028360A (ko) | 콜베 합성과 조합된 미생물을 이용한 알칸의 생산 방법 | |
| EP0015669B1 (en) | Microbiological process for the production of poly (beta-hydroxybutyric acid) and micro-organisms for use therein | |
| Samain et al. | Initial steps of catabolism of trihydroxybenzenes in Pelobacter acidigallici | |
| Zhang et al. | Pretreatment with a combination of steam explosion and NaOH increases butanol production of enzymatically hydrolyzed corn stover | |
| US9249431B2 (en) | Production process | |
| WO2011078709A1 (en) | Alcohol production process | |
| US20150037832A1 (en) | Methods of facilitating the bioconversion of crude biodiesel-derived glycerol by microorganisms | |
| JP2016530894A (ja) | 発酵プロセス | |
| Restiawaty et al. | Ferrous ion and medium composition effects on acidogenic phase in biobutanol production from molasses | |
| US20230383317A1 (en) | Medium composition including ethanol for production of 2,3-butanediol from synthetic gas and 2,3-butanediol production method using same | |
| WO2010095975A2 (en) | Method for regulation of ratio of organic solvents during biosynthesis | |
| ABIBU et al. | EFFECTS OF LOW AND ELEVATED SODIUM ION CONCENTRATIONS ON ACETONE-BUTANOL-ETHANOL (ABE) FERMENTATION AND BIOHYDRO-GEN PRODUCTION FROM WASTE FIG (Ficus carica) | |
| Fatma | Cassava (ManihOt esCulenta) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |